Metastases-directed therapy ( MDT ) with surgery or stereotactic body radiotherapy ( SBRT ) is emerging as a new treatment option for prostate cancer ( PCa ) patients with a limited number of metastases ( 3 ) at recurrence - so called `` oligometastases '' .